Haemonetics Corporation

Historical 13F Holders

Symbol
HAE
CUSIP
405024100
All holders as of
Q4 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q1 30 311 k $17.5 M
2025 Q4 350 45.9 M $3.68 B
2025 Q3 320 51.6 M $2.51 B
2025 Q2 320 55.6 M $4.13 B
2025 Q1 338 54.0 M $3.41 B
2024 Q4 338 56.8 M $4.41 B
2024 Q3 329 56.3 M $4.52 B
2024 Q2 334 56.4 M $4.67 B
2024 Q1 312 52.0 M $4.44 B
2023 Q4 316 51.4 M $4.40 B
2023 Q3 313 50.8 M $4.55 B
2023 Q2 312 50.6 M $4.30 B
2023 Q1 322 50.9 M $4.19 B
2022 Q4 312 52.1 M $4.10 B
2022 Q3 284 51.8 M $3.84 B
2022 Q2 252 52.1 M $3.39 B
2022 Q1 252 51.6 M $3.26 B
2021 Q4 277 50.2 M $2.66 B
2021 Q3 265 50.7 M $3.58 B
2021 Q2 276 50.7 M $3.38 B
2021 Q1 309 50.0 M $5.55 B
2020 Q4 304 51.4 M $6.10 B
2020 Q3 282 49.5 M $4.32 B
2020 Q2 306 49.6 M $4.44 B
2020 Q1 283 50.7 M $5.05 B
2019 Q4 306 50.7 M $5.83 B
2019 Q3 287 49.8 M $6.28 B
2019 Q2 273 51.6 M $6.21 B
2019 Q1 274 51.4 M $4.50 B
2018 Q4 288 51.5 M $5.15 B
2018 Q3 306 53.9 M $6.18 B
2018 Q2 302 51.3 M $4.60 B
2018 Q1 268 53.7 M $3.93 B
2017 Q4 252 53.6 M $3.12 B
2017 Q3 208 54.8 M $2.46 B
2017 Q2 198 55.5 M $2.19 B
2017 Q1 183 54.7 M $2.22 B
2016 Q4 200 53.1 M $2.13 B
2016 Q3 182 51.8 M $1.88 B
2016 Q2 181 53.7 M $1.56 B
2016 Q1 171 51.3 M $1.79 B
2015 Q4 167 51.7 M $1.67 B
2015 Q3 172 52.1 M $1.68 B
2015 Q2 181 53.4 M $2.21 B
2015 Q1 172 53.8 M $2.41 B
2014 Q4 176 54.7 M $2.05 B
2014 Q3 173 53.1 M $1.85 B
2014 Q2 178 55.4 M $1.95 B
2014 Q1 198 54.2 M $1.77 B